Role of Tutthakadi Malahara in the management of Dushta vrana with Special Reference to Diabetic Ulcer

A randomized open label controlled clinical study to evaluate the efficacy of Tutthakadi Malahara in the management of Dushta vrana with special reference to Diabetic ulcer - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069137

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 21-70 years irrespective of gender, religion,occupation,economic status and educational status. 2.Subjects with classical symptoms of Dushta Vrana such as Poothi Pooya, Dushta Asrk Srava, Utsangi, Chirasthitha, Athi Gandha. 3.Subjects with ulcer of diabetic foot with grade 1,2. 4.Subjects with ulcer size maximum up to 15into 10 cm. Subjects with controlled diabetes mellitus.

Exclusion criteria

Exclusion criteria: 1.Subjects with diabetic ulcer - grade 3(As per University of Texus classification of Diabetic Ulcers). 2.Subjects suffering from infectious disease like HIV, Hepatitis and Tuberculosis or other sexually transmitted infections 3.Subjects who are known cases of Leprosy and Bleeding disorders 4.Subjects suffering from Osteomyelitis. Subjects suffering from immunocompromised diseases.

Design outcomes

Primary

Measure	Time frame
To see the significant healing of Dushta Vrana w.s.r to Diabetic Ulcer assessed based on VAS Scale and Bates Jansen wound assessment toolTimepoint: 0th,7th,14th & 21stday	—

Secondary

Measure	Time frame
To improve the quality of life. Generation of in depth analysed data on the different aspect of the disease. Generation of data on possible unexpected drug reaction. Timepoint: 0th, 7th,14th & 21stday 28th and 35th day	—

Countries

India

Contacts

Public ContactDr Priyanka Chimulkar

Sri Sri College of Ayurvedic Science and Research

dhyan88@gmail.com9284180035

Outcome results